Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs. It aims to open the way for a broad range of disease-modifying therapies by modifying the intracellular and extracellular concentrations of these various electrolytes and ions in Chronic Kidney Disease and Gitelman’sSyndrome and by addressing the underlying mitochondrial pathology and inflammation associated with Acute Kidney Disease.Unicycive Therapeutics was founded in 2016 and is headquartered in Los Altos, California.

Health Diagnostics

Health Care

Biotechnology

Unicycive Therapeutics

Shalabh Gupta, MD

Hannah Haddox

Teresa Miller

Satya Medicherla

Pramod Gupta

John Townsend

Guru Reddy

Doug Jermasek

Atul Khare, Ph.D., M.B.A.

Leadership Team

Scientific and Clinical Development

Teams at Unicycive Therapeutics

Leadership Team

Scientific and Clinical Development